{"created":"2023-06-19T11:23:21.960026+00:00","id":3887,"links":{},"metadata":{"_buckets":{"deposit":"bdaf0bcd-330d-44cf-a88f-9e19210b1365"},"_deposit":{"created_by":3,"id":"3887","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"3887"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00003887","sets":["7","7:23"]},"author_link":["11693","11694"],"item_5_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-01-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"14","bibliographicPageStart":"2","bibliographicVolumeNumber":"29","bibliographic_titles":[{"bibliographic_title":"日本臨床麻酔学会誌"}]}]},"item_5_description_33":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"プロポフォールやフェンタニル,レミフェンタニルなどの静脈麻酔薬が,TCIの使用によりその効果部位濃度を意識して投与されるようになり,コントロールが容易になった中,筋弛緩薬に対して同様の意識をもって投与する者は少ない.ベクロニウムにおいて,理論上TCIは十分可能であるが,その際障害になるのはその代謝産物3-desacetyl vecuroniumの存在である.3-desacetyl vecuroniumはベクロニウムの80%の力価をもち,その薬物動態も考慮しなければ一定の筋弛緩効果を得ることは難しい.この代謝物を無視したTCIは実際の濃度と大きな差異を生じ,覚醒遅延を引き起こす原因になりうる.ロクロニウムはこのような薬理活性をもつ代謝物を産生せず,よりTCIに適した薬物であるといえる.","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_5_description_36":{"attribute_name":"注記","attribute_value_mlt":[{"subitem_description":"著者最終原稿版","subitem_description_type":"Other"}]},"item_5_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_5_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_5_source_id_22":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0285-4945","subitem_source_identifier_type":"PISSN"}]},"item_5_text_44":{"attribute_name":"ID(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"2009101868"}]},"item_5_text_54":{"attribute_name":"閲覧数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"581"}]},"item_5_text_55":{"attribute_name":"ダウンロード数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"2270"}]},"item_5_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Iwasaki, Hiroshi"},{"subitem_text_language":"en"}]},"item_5_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"笹川, 智貴","creatorNameLang":"ja"},{"creatorName":"ササカワ, トモキ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"11693","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"岩崎, 寛","creatorNameLang":"ja"},{"creatorName":"イワサキ, ヒロシ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"11694","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"4602.pdf","filesize":[{"value":"2.0 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"4602.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/3887/files/4602.pdf"},"version_id":"b77df73a-7726-45dd-9119-c2829e455640"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"薬物動態","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"ベクロニウム","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"ロクロニウム","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"Target controlled infusion(TCI)","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"神経筋接合部を意識した筋弛緩投与法とモニタリング 効果部位濃度を意識した筋弛緩薬投与","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"神経筋接合部を意識した筋弛緩投与法とモニタリング 効果部位濃度を意識した筋弛緩薬投与","subitem_title_language":"ja"}]},"item_type_id":"5","owner":"3","path":["6","7","23"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2012-06-14"},"publish_date":"2012-06-14","publish_status":"0","recid":"3887","relation_version_is_last":true,"title":["神経筋接合部を意識した筋弛緩投与法とモニタリング 効果部位濃度を意識した筋弛緩薬投与"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-07-26T09:06:22.357727+00:00"}